RHOA and asthma: Interlukin-13-dependent RhoA protein expression is negatively controlled by miR-140-3p in ASMs, according to a study, and the RhoA/Rho-kinase pathway has been suggested as a new target for the therapy of AHR in asthma [76, 77].